Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 5/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.68 |
| ▸ | MEN1 | O00255 | 2/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.66 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 4/20 | 0.39 |
| ▸ | RAB9A | P51151 | 4/20 | 0.39 |
| ▸ | PAX8 | Q06710 | 4/20 | 0.39 |
| ▸ | JAK2 | O60674 | 2/20 | 0.39 |
| ▸ | GPX4 | P36969 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | RNF4 | P78317 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alachlor SCHEMBL15501 | 1.00 | TP53 (1.00) | TP53TDP1MEN1KMT2AALDH1A1 | |
| Alachlor SCHEMBL27576906 | 0.98 | TP53 (0.97) | TP53TDP1MEN1KMT2AALDH1A1 | |
| Alachlor SCHEMBL22163774 | 0.98 | TP53 (0.97) | TP53TDP1MEN1KMT2AALDH1A1 | |
| Alachlor SCHEMBL27497168 | 0.98 | TP53 (0.97) | TP53TDP1MEN1KMT2AALDH1A1 | |
| Alachlor SCHEMBL27726836 | 0.98 | TP53 (0.97) | TP53TDP1MEN1KMT2AALDH1A1 | |
| Alachlor SCHEMBL27849719 | 0.97 | TP53 (0.94) | TP53TDP1MEN1KMT2AALDH1A1 | |
| Alachlor SCHEMBL28909519 | 0.96 | TP53 (0.91) | TP53TDP1MEN1KMT2AALDH1A1 | |
| Alachlor SCHEMBL2232228 | 0.94 | TP53 (0.89) | TP53TDP1MEN1KMT2AALDH1A1 | |
| Alachlor SCHEMBL20472768 | 0.93 | TP53 (0.86) | TP53TDP1MEN1KMT2AALDH1A1 | |
| Alachlor SCHEMBL28812777 | 0.93 | TP53 (0.86) | TP53TDP1MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240226160-A9 | ACTIVITY-INDUCIBLE FUSION PROTEINS HAVING A HEAT SHOCK PROTEIN 90 BINDING DOMAIN | SEATTLE CHILDREN'S HOSPITAL D/B/A SEATTLE CHILDREN'S RESEARCH INSTITUTE (US) | 2024-07-11 | — | — | US | disclosed |
| US-20240131072-A1 | ACTIVITY-INDUCIBLE FUSION PROTEINS HAVING A HEAT SHOCK PROTEIN 90 BINDING DOMAIN | SEATTLE CHILDREN'S HOSPITAL D/B/A SEATTLE CHILDREN'S RESEARCH INSTITUTE (US) | 2024-04-25 | — | — | US | disclosed |
| US-20230322925-A1 | PHOSPHOLIPID ETHER (PLE) CAR T CELL TUMOR TARGETING (CTCT) AGENTS | SEATTLE CHILDREN’S HOSPITAL DBA SEATTLE CHILDREN’S RES INSTITUTE (US) | 2023-10-12 | — | — | US | disclosed |
| US-20230172981-A1 | METHODS AND COMPOSITIONS FOR STIMULATION OF CHIMERIC ANTIGEN RECEPTOR T CELLS WITH HAPTEN LABELLED CELLS | SEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RES INST (US) | 2023-06-08 | — | — | US | disclosed |
| US-11649288-B2 | Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents | SEATTLE CHILDREN'S HOSPITAL (US) | 2023-05-16 | — | — | US | disclosed |
| US-20210317407-A1 | METHODS AND COMPOSITIONS FOR STIMULATION OF CHIMERIC ANTIGEN RECEPTOR T CELLS WITH HAPTEN LABELLED CELLS | Seattle Children's Hospital (dba Seattle Children's Research Institute) | 2021-10-14 | — | — | US | disclosed |
| US-20200087399-A1 | PHOSPHOLIPID ETHER (PLE) CAR T CELL TUMOR TARGETING (CTCT) AGENTS | Seattle Children's Hospital (dba Seattle Children's Research Institute) | 2020-03-19 | — | — | US | disclosed |
| WO-2009117621-A1 | PEST CONTROL COMPOSITIONS AND METHODS | TYRATECH, INC. (US) | 2009-09-24 | — | — | WO | disclosed |
| EP-2077724-A2 | PEST CONTROL COMPOSITIONS AND METHODS | Tyratech, Inc. (US) | 2009-07-15 | — | — | EP | disclosed |
| WO-2008088827-A2 | PEST CONTROL COMPOSITIONS AND METHODS | TYRATECH, INC. (US) | 2008-07-24 | — | — | WO | disclosed |
| EP-0457802-A1 | HERBICIDAL OXABICYCLONONANE ETHERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-11-27 | — | — | EP | disclosed |
| WO-1991010653-A1 | HERBICIDAL PYRIMIDINES AND TRIAZINES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-07-25 | — | — | WO | disclosed |
| WO-1991010668-A1 | HERBICIDAL SULFONYLUREAS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-07-25 | — | — | WO | disclosed |
| WO-1991003464-A1 | HERBICIDAL OXABICYCLO ETHERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-03-21 | — | — | WO | disclosed |
| WO-1990012012-A1 | SUBSTITUTED PHENYLTRIAZOLOPYRIMIDINE HERBICIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-10-18 | — | — | WO | disclosed |
| WO-1990010634-A1 | SELECTIVE OXABICYCLOALKANES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-09-20 | — | — | WO | disclosed |
| WO-1990009383-A1 | HERBICIDAL OXABICYCLONONANE ETHERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-08-23 | — | — | WO | disclosed |
| WO-1990002130-A2 | HERBICIDES FOR WEED CONTROL IN SUGAR BEETS, OILSEED RAPE AND COLE CROPS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-03-08 | — | — | WO | disclosed |
| EP-0334896-A1 | HERBICIDAL PYRIDINESULFONYLUREAS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-10-04 | — | — | EP | disclosed |
| WO-1988004297-A1 | HERBICIDAL PYRIDINESULFONYLUREAS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-06-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11649288-B2 | Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents | PHOSPHO1, LCAT, CD47 | TP53 207/4885TDP1 3519/4885MEN1 2203/4885 |
| US-20230322925-A1 | PHOSPHOLIPID ETHER (PLE) CAR T CELL TUMOR TARGETING (CTCT) AGENTS | PHOSPHO1, LCAT, CD47 | TP53 207/4885TDP1 3519/4885MEN1 2203/4885 |
| US-20200087399-A1 | PHOSPHOLIPID ETHER (PLE) CAR T CELL TUMOR TARGETING (CTCT) AGENTS | PHOSPHO1, LCAT, CD47 | TP53 207/4885TDP1 3519/4885MEN1 2203/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.